Biology subjects

Gratten, J.

Publications and source records attributed to Gratten, J..

7 recordsLinked to original sources

bioRxiv2020

Investigating the shared genetic architecture between multiple sclerosis and inflammatory bowel diseases

An epidemiological association between multiple sclerosis (MS) and inflammatory bowel disease (IBD) is well-established, but whether this reflects a shared genetic aetiology, and whether consistent genetic relationships exist between MS and the two predominant subtypes of IBD, ulcerative colitis (UC) and Crohns disease (CD), remains unclear. Here, we used genome-wide association study (GWAS) summary data to estimate genetic correlations (rg) between MS and each of IBD, UC and CD, finding that the rg between MS and UC was approximately twice that between MS and CD. On the basis of these genetic correlations, we performed cross-trait meta-analysis of GWAS summary data for MS and each of IBD, UC and CD, identifying a total of 42 novel SNPs shared between MS and IBD (N=19), UC (N=14), and CD (N=18). We then used multiple Mendelian randomization (MR) methods to investigate causal relationships between these diseases, finding suggestive but inconclusive evidence for a causal effect of MS on UC and IBD, and no or weak and inconsistent evidence for a causal effect of IBD or UC on MS. There was also no evidence for causality in bidirectional analyses of MS and CD. We also investigated tissue- and cell-type-specific enrichment of SNP heritability for each disease using stratified LD score regression. At the tissue level, we observed largely consistent patterns of enrichment for all four diseases in immune system-related tissues, including lung, spleen and whole blood, and in contrast to prior studies, small intestine. At the cell-type level, we identified significant enrichment for all diseases in CD4+ T cells in lung, and for MS, IBD and CD in CD8+ cytotoxic T cells in both lung and spleen, and regulatory T cells in lung. Our study sheds new insights into the biological basis of comorbidity between MS and both UC and CD.

genetics↗

bioRxiv2018

Parkinson disease age of onset GWAS: defining heritability, genetic loci and a-synuclein mechanisms

Increasing evidence supports an extensive and complex genetic contribution to Parkinsons disease (PD). Previous genome-wide association studies (GWAS) have shed light on the genetic basis of risk for this disease. However, the genetic determinants of PD age of onset are largely unknown. Here we performed an age of onset GWAS based on 28,568 PD cases. We estimated that the heritability of PD age of onset due to common genetic variation was ~0.11, lower than the overall heritability of risk for PD (~0.27) likely in part because of the subjective nature of this measure. We found two genome-wide significant association signals, one at SNCA and the other a protein-coding variant in TMEM175, both of which are known PD risk loci and a Bonferroni corrected significant effect at other known PD risk loci, INPP5F/BAG3, FAM47E/SCARB2, and MCCC1. In addition, we identified that GBA coding variant carriers had an earlier age of onset compared to non-carriers. Notably, SNCA, TMEM175, SCARB2, BAG3 and GBA have all been shown to either directly influence alpha-synuclein aggregation or are implicated in alpha-synuclein aggregation pathways. Remarkably, other well-established PD risk loci such as GCH1, MAPT and RAB7L1/NUCKS1 (PARK16) did not show a significant effect on age of onset of PD. While for some loci, this may be a measure of power, this is clearly not the case for the MAPT locus; thus genetic variability at this locus influences whether but not when an individual develops disease. We believe this is an important mechanistic and therapeutic distinction. Furthermore, these data support a model in which alpha-synuclein and lysosomal mechanisms impact not only PD risk but also age of disease onset and highlights that therapies that target alpha-synuclein aggregation are more likely to be disease-modifying than therapies targeting other pathways.

genetics↗

bioRxiv2018

The genetic relationship between female reproductive traits and six psychiatric disorders

Female reproductive behaviors have an important implication in evolutionary fitness and health of offspring. Previous studies have shown that age at first birth of women (AFB) is genetically associated with schizophrenia (SCZ). However, for most other psychiatric disorders and reproductive traits, the latent shared genetic architecture is largely unknown. Here we used the second wave of UK Biobank data (N=220,685) to evaluate the association between five female reproductive traits and polygenetic risk scores (PRS) projected from genome-wide association study summary statistics of six psychiatric disorders (N=429,178). We found that the PRS of attention-deficit/hyperactivity disorder (ADHD) were strongly associated with AFB (genetic correlation of -0.68 {+/-} 0.03 with p-value = 1.86E-89), age at first sexual intercourse (AFS) (-0.56 {+/-} 0.03 with p-value = 3.42E-60), number of live births (NLB) (0.36 {+/-} 0.04 with p-value = 4.01E-17) and age at menopause (-0.27 {+/-} 0.04 with p-value = 5.71E-13). There were also robustly significant associations between the PRS of eating disorder (ED) and AFB (genetic correlation of 0.35 {+/-} 0.06), ED and AFS (0.19 0.06), Major depressive disorder (MDD) and AFB (-0.27 {+/-} 0.07), MDD and AFS (- 0.27 {+/-} 0.03) and SCZ and AFS (-0.10 {+/-} 0.03). Our findings reveal the shared genetic architecture between the five reproductive traits in women and six psychiatric disorders, which have a potential implication that helps to improve reproductive health in women, hence better child outcomes. Our findings may also explain, at least in part, an evolutionary hypothesis that causal mutations underlying psychiatric disorders have positive effects on reproductive success.

genetics↗

bioRxiv2018

Improved prediction of chronological age from DNA methylation limits it as a biomarker of ageing

DNA methylation is associated with age. The deviation of age predicted from DNA methylation from actual age has been proposed as a biomarker for ageing. However, a better prediction of chronological age implies less opportunity for biological age. Here we used 13,661 samples (from blood and saliva) in the age range of 2 to 104 years from 14 cohorts measured on Illumina HumanMethylation450/EPIC arrays to perform prediction analyses. We show that increasing the sample size achieves a smaller prediction error and higher correlations in test datasets. We demonstrate that smaller prediction errors provide a limit to how much variation in biological ageing can be captured by methylation and provide evidence that age predictors from small samples are prone to confounding by cell composition. Our predictor shows a similar or better performance in non-blood tissues including saliva, endometrium, breast, liver, adipose and muscle, compared with Horvaths across-tissue age predictor.

bioinformatics↗

bioRxiv2018

Imprint of Assortative Mating on the Human Genome

Non-random mate-choice with respect to complex traits is widely observed in humans, but whether this reflects true phenotypic assortment, environment (social homogamy) or convergence after choosing a partner is not known. Understanding the causes of mate choice is important, because assortative mating (AM) if based upon heritable traits, has genetic and evolutionary consequences. AM is predicted under Fishers classical theory1 to induce a signature in the genome at trait-associated loci that can be detected and quantified. Here, we develop and apply a method to quantify AM on a specific trait by estimating the correlation ({theta}) between genetic predictors of the trait from SNPs on odd versus even chromosomes. We show by theory and simulation that the effect of AM can be distinguished from population stratification. We applied this approach to 32 complex traits and diseases using SNP data from [~]400,000 unrelated individuals of European ancestry. We found significant evidence of AM for height ({theta}=3.2%) and educational attainment ({theta}=2.7%), both consistent with theoretical predictions. Overall, our results imply that AM involves multiple traits, affects the genomic architecture of loci that are associated with these traits and that the consequence of mate choice can be detected from a random sample of genomes.

genetics↗

bioRxiv2017

Age at first birth in women is genetically associated with increased risk of schizophrenia

Previous studies have shown an increased risk for a range of mental health issues in children born to both younger and older parents compared to children of average-aged parents. However, until recently, it was not clear if these increased risks are due to psychosocial factors associated with age or if parents at higher genetic risk for psychiatric disorders tend to have children at an earlier or later age. We previously used a novel design to reveal a latent mechanism of genetic association between schizophrenia and age of mothers at the birth of their first child (AFB). Here, we use independent data from the UK Biobank (N=38,892) to replicate the finding of an association between predicted genetic risk of schizophrenia and AFB in women, end to estimate the genetic correlation between schizophrenia and AFB in women stratified into younger and older groups. We find evidence for an association between predicted genetic risk of schizophrenia and AFB in women (P-value=1.12E-05), and we show genetic heterogeneity between younger and older AFB groups (P-value=3.45E-03). The genetic correlation between schizophrenia and AFB in the younger AFB group is -0.16 (SE=0.04) while that between schizophrenia and AFB in the older AFB group is 0.14 (SE=0.08). Our results suggest that early, and perhaps also late, age at first birth in women is associated with increased genetic risk for schizophrenia. These findings contribute new insights into factors contributing to the complex bio-social risk architecture underpinning the association between parental age and offspring mental health.

genetics↗

bioRxiv2017

New mutations, old statistical challenges

Based on targeted sequencing of 208 genes in 11,730 neurodevelopmental disorder cases, Stessman et al. report the identification of 91 genes associated (at a False Discovery Rate [FDR] of 0.1) with autism spectrum disorders (ASD), intellectual disability (ID), and developmental delay (DD)--including what they characterize as 38 novel genes, not previously reported as connected with these diseases1.\n\nIf true, this would represent a substantial step forward. Unfortunately, each of the two discovery analyses (1. De novo mutation analysis and, 2. a comparison of private mutations with public control data) contain critical statistical flaws. When one accounts for these problems, fewer than half of the genes--and very few, if any, of the novel findings--survive. These errors have implications for how future analyses should be conducted, for understanding the genetic basis of these disorders, and for genomic medicine.\n\nWe discuss the two main ana ...

genetics↗